Transcriptional regulation of WNT2B based on the balance of Hedgehog, Notch, BMP and WNT signals

International Journal of Oncology

Volumn 34, Issue 5, 2009, Pages 1411-1415

  Katoh, Masuko ^a   Katoh, Masaru ^b  

^a M&M Medical BioInformatics   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

Author keywords

Basal cell carcinoma; BMP; Breast cancer; Gastric cancer; Hedgehog; Nutch; Stem cell signaling network; Systems biology; WNT

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; HEPATOCYTE NUCLEAR FACTOR 3BETA; PROCOLLAGEN C PROTEINASE; PROTEIN WNT2B; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR FOXE1; TRANSCRIPTION FACTOR FOXF1; TRANSCRIPTION FACTOR FOXL1; TRANSCRIPTION FACTOR GLI1; UNCLASSIFIED DRUG; WNT2 PROTEIN;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CARCINOGENESIS; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENETIC ANALYSIS; HOMEOSTASIS; HUMAN; INTESTINE EPITHELIUM CELL; MALIGNANT NEOPLASTIC DISEASE; MESENCHYME CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

BASE SEQUENCE; BINDING SITES; BONE MORPHOGENETIC PROTEINS; COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GLYCOPROTEINS; HEDGEHOG PROTEINS; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; RECEPTORS, NOTCH; SEQUENCE HOMOLOGY, NUCLEIC ACID; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; WNT PROTEINS;

EID: 67649424214     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000269     Document Type: Article

References (70)

1. Katoh M: WNT and FGF gene clusters. Int J Oncol 21: 1269-1273, 2002.
2. Katoh M: Regulation of WNT signaling molecules by retinoic acid during neuronal differentiation in NT2 cells: Threshold model of WNT action. Int J Mol Med 10: 683-687, 2002.
3. Nusse R: Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface. Development 130: 5297-5305, 2003.
4. Moon RT, Kohn AD, De Ferrari GV and Kaykas A: WNT and ß-catenin signalling: diseases and therapies. Nat Rev Genet 5: 691-701, 2004.
5. Clevers H: Wnt/ß-catenin signaling in development and disease. Cell 127: 469-480, 2006.
6. Katoh M, Hirai M, Sugimura T and Terada M: Cloning, expression and chromosomal localization of Wnt13, a novel member of the Wnt gene family. Oncogene 13: 873-876, 1996.
7. Zakin LD, Mazan S, Maury M, Martin N, Guénet JL and Brûlet P: Structure and expression of Wnt13. Mech Dev 73: 107-116, 1998.
8. Jasoni C, Hendrickson A and Roelink H: Analysis of chicken Wnt-13 expression demonstrates coincidence with cell division in the developing eye and is consistent with a role in induction. Dev Dyn 215: 215-224, 1999.
9. Fischer S, Draper BW and Neumann CJ: The zebrafish fgf24 mutant identifies an additional level of Fgf signaling involved in vertebrate forelimb initiation. Development 130: 3515-3524, 2003.
10. Katoh M: WNT2B: comparative integromics and clinical applications. Int J Mol Med 16: 1103-1108, 2005.
11. Katoh M, Kirikoshi H, Saitoh T, Sagara N and Koike J: Alternative splicing of the WNT2B/WNT13 gene. Biochem Biophys Res Commun 275: 209-216, 2000.
12. Katoh M, Kirikoshi H, Terasaki H and Shiokawa K: WNT2B2 mRNA, upregulated in primary gastric cancer, is a positive regulator of the WNT-ß-catenin-TCF signaling pathway. Biochem Biophys Res Commun 289: 1093-1098, 2001.
13. Jiang J and Struhl G: Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb. Nature 391: 493-496, 1998.
14. ß-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and ß-catenin and stimulates IκBα ubiquitination in vitro. Genes Dev 13: 270-283, 1999.
15. Koike J, Sagara N, Kirikoshi H, Takagi A, Miwa T, Hirai M and Katoh M: Molecular cloning and genomic structure of the βTRCP2 gene on chromosome 5q35.1. Biochem Biophys Res Commun 269: 103-109, 2000.
16. Saitoh T and Katoh M: Expression profiles of βTRCP1 and βTRCP2, and mutation analysis of βTRCP2 in gastric cancer. Int J Oncol 18: 959-964, 2001.
17. Spiegelman VS, Tang W, Katoh M, Slaga TJ and Fuchs SY: Inhibition of HOS expression and activities by Wnt pathway. Oncogene 21: 856-860, 2002.
18. Wong HC, Bourdelas A, Krauss A, et al: Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled. Mol Cell 12: 1251-1260, 2003.
19. Tolwinski NS, Wehrli M, Rives A, Erdeniz N, DiNardo S and Wieschaus E: Wnt signal can be transmitted through LRP5/6 and Axin independently of GSK3ß activity. Dev Cell 4: 407-418, 2003.
20. Katoh M and Katoh M: WNT signaling pathway and stem cell signaling network. Clin Cancer Res 13: 4042-4045, 2007.
21. Korinek V, Barker N, Morin PJ, et al: Constitutive transcriptional activation by a ß-catenin-Tcf complex in APC-/-colon carcinoma. Science 275: 1784-1787, 1997.
22. He TC, Sparks AB, Rago C, et al: Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512, 1998.
23. Tetsu O and McCormick F: ß-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426, 1999.
24. Garciadiego-Cazares D, Rosales C, Katoh M and Chimal-Monroy J: Coordination of chondrocyte differentiation and joint formation by α5ß1 integrin in the developing appendicular skeleton. Development 131: 4735-4742, 2004.
25. Katoh M: WNT signaling in stem cell biology and regenerative medicine. Curr Drug Targets 9: 565-570, 2008.
26. Bailey J, Singh PK and Hollingsworth MA: Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenetic proteins. J Cell Biochem 102: 829-839, 2007.
27. Katoh M: Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change, and genetic alteration in gastric cancer. Cancer Biol Ther 6: 832-839, 2007.
28. Katoh M: Cancer genomics and genetics of FGFR2. Int J Oncol 33: 233-237, 2008.
29. Katoh Y and Katoh M: Hedgehog signaling, epithelial-to-mesenchymal transition, and miRNA. Int J Mol Med 22: 271-275, 2008.
30. Van den Berg DJ, Sharma AK, Bruno E and Hoffman R: Role of members of the Wnt gene family in human hematopoiesis. Blood 92: 3189-3202, 1998.
31. Katoh M: Differential regulation of WNT2 and WNT2B expression in human cancer. Int J Mol Med 8: 657-660, 2001.
32. Bonifas JM, Pennypacker S, Chuang PT, et al: Activation of expression of Hedgehog target genes in basal cell carcinomas. J Invest Dermatol 116: 739-742, 2001.
33. Rhee CS, Sen M, Lu D, et al: Wnt and Frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene 21: 6598-6605, 2002.
34. Benhaj K, Akcali KC and Ozturk M: Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Oncol Rep 15: 701-707, 2006.
35. Tanaka A, Leung PS, Kenny TP, et al: Genomic analysis of differentially expressed genes in liver and biliary epithelial cells of patients with primary biliary cirrhosis. J Autoimmun 17: 89-98, 2001.
36. You J, Nguyen AV, Albers CG, Lin F and Holcombe RF: Wnt pathway-related gene expression in inflammatory bowel disease. Dig Dis Sci 53: 1013-1019, 2008.
37. Katoh Y and Katoh M: Conserved POU-binding site linked to SP1-binding site within FZD5 promoter. Int J Oncol 30: 751-755, 2007.
38. Katoh M and Katoh M: Comparative integromics on FZD7 orthologs. Int J Mol Med 19: 529-533, 2007.
39. Katoh Y and Katoh M: Comparative genomics on PROM1 gene encoding stem cell marker CD133. Int J Mol Med 19: 967-970, 2007.
40. Katoh M and Katoh M: Conserved POU/OCT- and GATA-binding sites in 5′-flanking promoter region of mammalian WNT8B orthologs. Int J Oncol 30: 1273-1277, 2007.
41. Katoh M and Katoh M: Comparative integromics on JMJD1C gene encoding histone demethylase. Int J Oncol 31: 219-223, 2007.
42. Katoh Y and Katoh M: Comparative integromics on JMJD2A, JMJD2B and JMJD2C. Int J Mol Med 20: 269-273, 2007.
43. Katoh M and Katoh M: Comparative integromics on non-canonical WNT or planar cell polarity signaling molecules. Int J Mol Med 20: 405-409, 2007.
44. Katoh Y and Katoh Y: Integrative genomic analyses on GLI2. Int J Oncol 33: 881-886, 2008.
45. Katoh M: Molecular evolution of WNT2B orthologs. Int J Oncol 26: 1135-1139, 2005.
46. Beachy PA, Karhadkar SS and Berman DM: Tissue repair and stem cell renewal in carcinogenesis. Nature 432: 324-331, 2004.
47. Hooper JF and Scott MP: Communicating with Hedgehogs. Nat Rev Mol Cell Biol 6: 306-317, 2005.
48. Katoh Y and Katoh M: Hedgehog signaling pathway and gastrointestinal stem cell signaling network. Int J Mol Med 18: 1019-1023, 2006.
49. Hahn H, Wicking C, Zaphiropoulos PG, et al: Mutations of the human homologue of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85: 841-851, 1996.
50. Johnson RL, Rothman AL, Xie J, et al: Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272: 1668-1671, 1996.
51. Epstein EH: Basal cell carcinomas: attack of the Hedgehog. Nat Rev Cancer 8: 743-754, 2008.
52. Berman DM, Karhadkar SS, Maitra A, et al: Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumors. Nature 425: 846-851, 2003.
53. Katoh Y and Katoh M: Hedgehog signaling in gastric cancer. Cancer Biol Ther 4: 1050-1054, 2005.
54. Kubo M, Nakamura M, Tasaki A, et al: Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Res 64: 6071-6074, 2004.
55. Hardwick JC, Kodach L, Offerhaus J and van den Brink GR: BMP signaling in colorectal cancer. Nat Rev Cancer 8: 806-812, 2008.
56. Hollnagel A, Oehlmann V, Heymer J, Ruther U and Nordheim A: Id genes are direct targets of BMP induction in embryonic stem cells. J Biol Chem 274: 19838-19845, 1999.
57. Dahlqvist C, Blokzijl A, Chapman G, et al: Functional Notch signaling is required for BMP4-induced inhibition of myogenic differentiation. Development 130: 6089-6099, 2003.
58. Seki K and Hata A: Indian Hedgehog gene is a target of the BMP signaling pathway. J Biol Chem 279: 18544-18549, 2004.
59. Gregorieff A, Pinto D, Begthel H, Destrée O, Kielman M and Clevers H: Expression pattern of WNT signaling components in the adult intestine. Gastroenterology 129: 626-638, 2005.
60. Van den Brink GR, Bleuming SA, Hardwick JC, et al: Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation. Nat Genet 36: 277-282, 2004.
61. Katoh M: Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis. Stem Cell Rev 3: 30-38, 2007.
62. Meyer N and Penn LZ: Reflecting on 25 years with MYC. Nat Rev Cancer 8: 976-990, 2008.
63. Willert J, Epping M, Pollack JR, Brown PO and Nusse R: A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev Biol 2: 8, 2002.
64. Artavanis-Tsakonas S, Rand MD and Lake RJ: Notch signaling: cell fate control and signal integration in development. Science 284: 770-776, 1999.
65. Radtke F and Raj K: The role of Notch in tumorigenesis: oncogene or tumor suppressor? Nat Rev Cancer 3: 765-767, 2003.
66. Katoh M and Katoh M: Notch signaling in gastrointestinal tract. Int J Oncol 30: 247-251, 2007.
67. Katoh M and Katoh M: Integrative genomic analyses on HES/HEY family. Int J Oncol 31: 461-466, 2007.
68. Karin M: NF-κB in cancer development and progression. Nature 441: 431-436, 2006.
69. Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature 454: 436-444, 2008.
70. Kasperczyk H, Baumann B, Debatin KM and Fulda S: Characterization of sonic hedgehog as a novel NF-κB target gene that promotes NF-κB-mediated apoptosis resistance and tumor growth in vivo. FASEB J 23: 21-33, 2009.